Krystal Biotech to Present at H.C. Wainwright 24th Annual Global Investment Conference
08 September 2022 - 9:00PM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in
redosable gene therapy, announced today that the Company will
participate in the H.C. Wainwright 24th Annual Global Investment
Conference in New York from September 12-14.
Krish Krishnan, Chairman and Chief Executive Officer, will
deliver a presentation and host investor meetings on September
13.
A webcast of the presentation will be available here beginning
at 2:30pm ET on Tuesday, September 13 and will be posted on the
Investor section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene
therapy company leveraging its proprietary, redosable gene therapy
platform and in-house manufacturing capabilities to develop
life-changing medicines for patients with serious diseases,
including rare diseases in skin, lung, and other areas. For more
information please visit http://www.krystalbio.com, and follow
@KrystalBiotech on LinkedIn and Twitter.
CONTACT:Investors and
Media:
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com
Source: Krystal Biotech, Inc.
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2023 to Jul 2024